Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFN<i>α</i>-2a in Patients with Chronic Hepatitis B and the Associated Mechanism

<table class="table-group" id="tab9"><tr><td><table class="table"><tr><td class="thead-hr" colspan="7"><hr/></td></tr><tr class="thead"><td class="align_left">Degrees of steatosis</td><td class="align_center">Total cases</td><td class="align_center">0</td><td class="align_center">1</td><td class="align_center">2</td><td class="align_center">3</td><td class="align_center">Rank test</td></tr><tr><td class="thead-hr" colspan="7"><hr/></td></tr><tr><td class="align_left">S0</td><td class="align_center">119</td><td class="align_center">8</td><td class="align_center">28</td><td class="align_center">20</td><td class="align_center">63</td><td class="align_center" rowspan="4">0.257</td></tr><tr><td class="align_left">S1</td><td class="align_center">76</td><td class="align_center">10</td><td class="align_center">13</td><td class="align_center">17</td><td class="align_center">36</td></tr><tr><td class="align_left">S2</td><td class="align_center">22</td><td class="align_center">3</td><td class="align_center">4</td><td class="align_center">5</td><td class="align_center">10</td></tr><tr><td class="align_left">S3</td><td class="align_center">9</td><td class="align_center">0</td><td class="align_center">1</td><td class="align_center">3</td><td class="align_center">5</td></tr><tr class="table-tr"><td colspan="7"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The difference in HBcAg expression levels in different degrees of steatosis.</div>

Gastroenterology Research and Practice

tab9

Table 9

Table 9: Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFN<i>α</i>-2a in Patients with Chronic Hepatitis B and the Associated Mechanism 

Gastroenterology Research and Practice

Impact of Hepatic Steatosis on the Antiviral Effects of PEG-IFNα-2a in Patients with Chronic Hepatitis B and the Associated Mechanism

Table 9